About AiCure
AiCure is a Healthcare company based in New York (United States) founded in 2010 by Gordon Kessler. Medication adherence is visually confirmed via AI platform. It operates in the Healthcare and Technology sectors. AiCure has raised $59.75 million across 12 funding rounds from investors including SVB, New Leaf Venture Partners and HHS. The company has 16 employees. Its chief executive, as recorded, is Edward Ikeguchi. AiCure offers products and services including H.Code, eCOA - ePRO, and Adherence and Dosing. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials. Its competitors include Wellth, Cureatr and Phil; 3 of its 3 listed competitors have raised funding.
Company details
AiCure was established in 2010 in New York, United States, as a SaaS provider in the health technology sector. An AI-based platform is utilized to monitor medication adherence through visual verification in clinical trials and routine care settings. Machine learning, computer vision, and big data are applied via mobile devices, with patented facial recognition and motion-sensing features employed to observe patient actions during medication intake.
- Headquarters New York, United States
- Employees 16
- Founders Gordon Kessler
- SectorsHealthcareTechnology
- Email••••••••
- Phone•••• ••••
- Website aicure.com
- Social LinkedIn X
- Total Equity Funding$59.75M (USD)
in 12 rounds
- Latest Funding Round$4M (USD), Series C
Jan 2024
- InvestorsSVB
& 13 more
- Employee Count16
Products & Services of AiCure
AiCure offers a comprehensive portfolio of products and services, including H.Code, eCOA - ePRO, and Adherence and Dosing.
AI tool for monitoring and assisting clinical trial participants.
Captures participant responses to support trial data collection.
Tracks participant adherence to prevent trial dropouts.
Funding Insights of AiCure
AiCure has successfully raised a total of $59.75M across 12 strategic funding rounds. The most recent funding activity was a Series C round of $4 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $59.75M
- Total Rounds 12
- Last Round Series C — $4M
- First Round $273,165
(Sep 2011)
- Investors Count 14
Latest 10 of 12 funding rounds of AiCure with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2024 | $4M | Series C | – | – | – |
| Jan 2024 | $12M | Debt – Conventional | – | – | – |
| Jan 2024 | $4M | Series C | – | – | – |
| Nov 2019 | $24.5M | Series C | – | Palisades Growth Capital | |
| Jun 2017 | $15M | Series B | – | – | – |
| Jan 2016 | $12.25M | Series A | – | New Leaf Venture Partners | |
| Nov 2013 | $1M | Grant | – | – | |
| Jun 2013 | $1.8M | Grant | – | – | |
| Jun 2013 | $1.78M | Grant | – | – | |
| Aug 2012 | $227,209 | Grant | – | – |
14 investors in total: 14 institutional.
Investors in AiCure
AiCure has secured backing from 14 investors, including venture fund and institutional investors. Prominent investors backing the company include SVB, New Leaf Venture Partners and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| palisadesgrowth.com | ||||
Tech & Life-Sciences focused Stage-agnostic VC firm investing in geographies such as North America | springrockventures.com | Seattle, United States | ||
Venture capital investments are backed by Singtel through Innov8. | 2010 | innov8.singtel.com | Singapore, Singapore | |
Investments in SaaS, marketplace, and middle market companies are managed. | pritzkergroup.com | Chicago, United States | ||
Stage-agnostic investments in US life sciences are managed. | 2005 | nlvpartners.com | New York, United States | |
Early-stage tech and life sciences focused VC firm investing primarily in the US | biomaticscapital.com | Seattle, United States | ||
Global private equity and venture capital investments in B2B Tech & Services companies. | bairdcapital.com | |||
Early-stage VC firm investing in the US | tribecavp.com | New York, United States | ||
| accelmed-ventures.com | ||||
Innovative global companies are supported through venture capital investments by Asahi Kasei Ventures. | 1922 | asahikaseiventures.com | Tokyo, Japan |
Investor details for AiCure
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of AiCure
17 people are tracked at AiCure (11 in leadership, 6 in team); the tracked headcount is 16.
| Name | Role | Group |
|---|---|---|
Gordon Kessler | Co-Founder | Leadership |
Edward Ikeguchi | CEO | Leadership |
Julia Gapour | Sr. Director, Quality Assurance | Leadership |
Haiyan Wei | Senior Vice President, Technology And Operations | Leadership |
Megan Gross | Director, Project Delivery & Research (head) | Leadership |
Neelima Guntu | Associate Director SQA | Leadership |
Joshua Wilson | Chief Operating Officer | Leadership |
Cheryl Provorny, CFA | Vice President Finance | Leadership |
Barry Young | Associate Director Project Management | Leadership |
Leesandra Lopez | Associate Director | Leadership |
John Stanton | Marketing Director | Leadership |
Irene Mantikas | Senior Project Manager | Team |
Alexis Jennings | Manager, Contracts | Team |
Jiaxia (Joyce) Zhang, CPA | Accounting Manager | Team |
Moneisha Cran | Senior Data Manager | Team |
Matthew Burlew | Senior Data Analyst | Team |
Ashley Cummings | Clinical Site Lead | Team |
Complete people profiles for AiCure
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of AiCure
3 dated milestones of AiCure across 14 years, from founding to its latest funding, stage changes and deals.
- Founded AiCure is founded.
- Funding First funding round of $273K.
- Funding Latest funding round, Series C, of $4.0M.
Competitors of AiCure
AiCure has 3 listed competitors in our database, 3 of them funded. They include Wellth, Cureatr and Phil.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| wellthapp.com | 2014 | Brooklyn, United States | $73.12M | 65 | Provides AI and cloud-based platform for doctors for patient engagement and care | |
| cureatr.com | 2011 | New York, United States | $40.75M | Cloud-based medication management software is provided for healthcare providers. | ||
| phil.us | 2015 | San Francisco, United States | $105.54M | 99 | Prescription drugs refill management solutions |
Detailed competitors of AiCure
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of AiCure
The website of AiCure (aicure.com) receives about 4.5K visits a month.
- Monthly visits4.5K
▲ 15.1% vs previous month
Websites whose visitors overlap most with AiCure. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| notablehealth.com | 100% | 18.8K | #1,445,552 | View details | |
| curaihealth.com | 84% | 46.2K | #387,906 | View details | |
| medidata.com | 50% | 87K | #373,122 | View details |
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as AiCure (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Aicure
Complete news archive for AiCure
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AiCure
AiCure was founded in 2010 and raised its 1st funding round 1 year after it was founded.
AiCure is headquartered in New York, United States. It is registered at New York, New York, United States.
Edward Ikeguchi is the CEO of AiCure, as recorded in our data.
AiCure is a funded company, having raised a total of $59.75M across 12 funding rounds to date. The company's 1st funding round was a Grant of $227.21K, raised on Sep 2011.
AiCure has 16 employees.
AiCure was established in 2010 in New York, United States, as a SaaS provider in the health technology sector. An AI-based platform is utilized to monitor medication adherence through visual verification in clinical trials and routine care settings. Machine learning, computer vision, and big data are applied via mobile devices, with patented facial recognition and motion-sensing features employed to observe patient actions during medication intake.
AiCure offers H.Code, eCOA - ePRO, and Adherence and Dosing.
AiCure has 14 investors. Key investors include SVB, New Leaf Venture Partners, HHS, Singtel Innov8, and Palisades Growth Capital.